Pharma Report

Promoting population health through pharmaceutical policy
The role of the UK Voluntary Scheme

"Since 2018, the National Health Service (NHS) spending on branded medicines has been increasing annually by over 5 per cent, excluding expenditure on COVID-19 vaccines and treatments. In the fiscal year 2021-22, the total cost of prescription medicines to the NHS in England, after accounting for confidential discounts and rebates, reached £17.2 billion. A significant portion of this growth can be attributed to increased expenditure on hospital-prescribed medicines. From 2018 to 2022, NHS spending on hospital-prescribed medicines, net of confidential discounts, increased by 35 per cent from £6.7 billion to £9.1 billion."